Dragon Pharma MOTS-C
For athletes, bodybuilders, and fitness enthusiasts, cellular energy production is the foundation of performance. MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a recently discovered mitochondrial-derived peptide (MDP) that plays a critical role in metabolic regulation, insulin sensitivity, and energy homeostasis. This Dragon Pharma MOTS-C 10mg offering delivers high-purity lyophilized powder in a sterile 2mL vial, providing researchers with a premium compound for advanced metabolic, endurance, and cellular energy research.
MOTS-C is encoded within mitochondrial DNA and functions as a hormone that communicates metabolic status between mitochondria and the rest of the cell. It activates AMPK (AMP-activated protein kinase), the body's master metabolic switch, promoting glucose uptake, fatty acid oxidation, and mitochondrial biogenesis. Research published in the NIH PubMed database demonstrates that MOTS-C increases insulin sensitivity, enhances glucose utilization in skeletal muscle, and promotes metabolic adaptations similar to those seen with exercise. These properties make MOTS-C a valuable tool for research into metabolic disorders, exercise physiology, and cellular energy optimization.
The relevance of MOTS-C to the athletic and bodybuilding community is significant. Cellular energy production directly impacts training capacity, recovery, and body composition. MOTS-C's ability to activate AMPK and promote fatty acid oxidation can support fat loss goals while enhancing glucose disposal—a critical factor for athletes managing insulin sensitivity. Additionally, MOTS-C has been shown to increase endurance capacity and promote metabolic flexibility, allowing the body to efficiently switch between fuel sources during training. Unlike many metabolic compounds, MOTS-C works at the mitochondrial level, addressing the fundamental drivers of cellular energy production. The 10mg vial provides a convenient size for research protocols.
Quality assurance is paramount in peptide research. Each batch of our MOTS-C 10 mg inventory undergoes rigorous third-party HPLC-MS testing to verify purity and dosage. Lab test documentation will be available shortly, reflecting Dragon Pharma's commitment to transparency and quality across all products.
For bodybuilders and strength athletes researching advanced metabolic strategies, MOTS-C offers a unique tool for studying mitochondrial function, energy metabolism, and insulin sensitivity. Its role as a mitochondrial-derived hormone makes it valuable for research into metabolic flexibility, endurance capacity, and cellular energy optimization. Whether investigating strategies for enhanced fat oxidation, improved insulin sensitivity, or metabolic conditioning, Dragon Pharma's MOTS-C delivers the purity, potency, and reliability required for serious research into mitochondrial and metabolic pathways.
Note: This product is intended for laboratory research and scientific investigation purposes only. Not for human consumption or veterinary use.
Usage Guidelines
MOTS-C is supplied as a sterile lyophilized powder and must be reconstituted with bacteriostatic water prior to research use. For optimal stability, gently swirl the vial after adding the diluent—do not shake vigorously. Standard research protocols involve reconstituting the 10mg peptide with 2-4mL of bacteriostatic water, yielding a concentration of 2.5-5mg/mL. Typical research dosing ranges from 0.5-2mg per administration, often administered 2-3 times weekly via subcutaneous injection. Due to its role in AMPK activation and metabolic regulation, dosing frequency varies based on research objectives. It is recommended to store the reconstituted peptide in a refrigerator (2-8°C) and use within 30 days to maintain peptide integrity.
For researchers investigating comprehensive metabolic and endurance protocols, combining MOTS-C with complementary compounds can yield synergistic insights. Consider exploring the following Dragon Pharma products to enhance your research:
- AICAR: An AMPK activator studied alongside MOTS-C for complementary effects on metabolic pathways.
- GW501516: A PPARδ agonist for comparative research on fatty acid oxidation pathways.
- SS-31: A mitochondrial-targeted peptide studied for cellular energy optimization.